{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:32:01Z","timestamp":1789104721758,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejso.2021.02.026","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T22:23:24Z","timestamp":1614723804000},"page":"1588-1592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-869X","authenticated-orcid":false,"given":"Shinsuke","family":"Sasada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-9378","authenticated-orcid":false,"given":"Yuri","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Masumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Emi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Arihiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2021.02.026_bib1","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J Clin"},{"issue":"15","key":"10.1016\/j.ejso.2021.02.026_bib2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","article-title":"Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness","volume":"375","author":"Welch","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ejso.2021.02.026_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jjco\/hyf025","article-title":"Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification","volume":"32","author":"Ichizawa","year":"2002","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.02.026_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10549-019-05339-0","article-title":"The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer","volume":"177","author":"Sasada","year":"2019","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejso.2021.02.026_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejrad.2017.02.046","article-title":"Higher breast cancer conspicuity on dbPET compared to WB-PET\/CT","volume":"90","author":"Nishimatsu","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2021.02.026_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clinimag.2018.05.010","article-title":"Which type of breast cancers is undetectable on ring-type dedicated breast PET?","volume":"51","author":"Sasada","year":"2018","journal-title":"Clin Imag"},{"issue":"2","key":"10.1016\/j.ejso.2021.02.026_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00259-017-3830-1","article-title":"Texture analysis of high-resolution dedicated breast (18) F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer","volume":"45","author":"Moscoso","year":"2018","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"10.1016\/j.ejso.2021.02.026_bib8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2214\/ajr.174.4.1741005","article-title":"FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features","volume":"174","author":"Berger","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2021.02.026_bib9","series-title":"WHO classification of tumours: breast Tumours","author":"Organization","year":"2019"},{"issue":"2","key":"10.1016\/j.ejso.2021.02.026_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 WHO classification of tumours of the breast","volume":"77","author":"Hoon Tan","year":"2020","journal-title":"Histopathology"},{"issue":"16","key":"10.1016\/j.ejso.2021.02.026_bib11","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"10.1016\/j.ejso.2021.02.026_bib12","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.02.026_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.ejso.2021.02.026_bib14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.breast.2013.05.003","article-title":"Role of FDG-PET\/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer","volume":"22","author":"Ohara","year":"2013","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ejso.2021.02.026_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-013-2687-7","article-title":"Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography\/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study","volume":"141","author":"Kadoya","year":"2013","journal-title":"Breast Canc Res Treat"},{"issue":"1","key":"10.1016\/j.ejso.2021.02.026_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-015-3303-9","article-title":"Utility of (18)F FDG-PET\/CT for predicting prognosis of luminal-type breast cancer","volume":"150","author":"Aogi","year":"2015","journal-title":"Breast Canc Res Treat"},{"issue":"4","key":"10.1016\/j.ejso.2021.02.026_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00259-019-4259-5","article-title":"Prediction of biological characteristics of breast cancer using dual-phase FDG PET\/CT","volume":"46","author":"Sasada","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"10.1016\/j.ejso.2021.02.026_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2967\/jnumed.113.126102","article-title":"A\u00a0molecular approach to breast imaging","volume":"55","author":"Fowler","year":"2014","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.ejso.2021.02.026_bib19","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1118\/1.4945271","article-title":"Performance evaluation of a high resolution dedicated breast PET scanner","volume":"43","author":"Garcia Hernandez","year":"2016","journal-title":"Med Phys"},{"issue":"10","key":"10.1016\/j.ejso.2021.02.026_bib20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2967\/jnumed.111.100958","article-title":"Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation","volume":"53","author":"Iima","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.ejso.2021.02.026_bib21","series-title":"NCCN clinical practice guidelines in Oncology (NCCN Guidelines\u00ae): breast cancer (version 5.2020)","year":"2020"},{"issue":"2","key":"10.1016\/j.ejso.2021.02.026_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10549-020-05861-6","article-title":"Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type","volume":"184","author":"Kim","year":"2020","journal-title":"Breast Canc Res Treat"},{"issue":"8","key":"10.1016\/j.ejso.2021.02.026_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1634\/theoncologist.2014-0108","article-title":"Rare breast cancer subtypes: histological, molecular, and clinical peculiarities","volume":"19","author":"Dieci","year":"2014","journal-title":"Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2021.02.026_bib24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MNM.0000000000000856","article-title":"Role of 18F-FDG PET\/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer","volume":"39","author":"Arslan","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.ejso.2021.02.026_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jjco\/hyn019","article-title":"Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in primary breast cancer","volume":"38","author":"Ueda","year":"2008","journal-title":"Jap J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2021.02.026_bib26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.106.035774","article-title":"Partial-volume effect in PET tumor imaging","volume":"48","author":"Soret","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.ejso.2021.02.026_bib27","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.21873\/anticanres.14336","article-title":"Classification of abnormal findings on ring-type dedicated breast PET for the detection of breast cancer","volume":"40","author":"Sasada","year":"2020","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ejso.2021.02.026_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.3032","article-title":"Immunophenotypic and genomic characterization of papillary carcinomas of the breast","volume":"226","author":"Duprez","year":"2012","journal-title":"J\u00a0Pathol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:38:25Z","timestamp":1760060305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0748798321001177"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.02.026","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}